EcoDrugPlus

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSPEMG00000011714
Gene Symbol: WEE1
3 Cross references
226 Possible Orthologues:

A Disintegrin And Metallopeptidase Domain 17

Ensembl ID : ENSPEMG00000015840
Gene Symbol: ADAM17
1 Cross references
282 Possible Orthologues:

Acetylcholinesterase (Cartwright Blood Group)

Ensembl ID : ENSPEMG00000012349
Gene Symbol: ACHE
3 Cross references
233 Possible Orthologues:

Activin A Receptor Like Type 1

Ensembl ID : ENSPEMG00000012111
Gene Symbol: ACVRL1
3 Cross references
353 Possible Orthologues:

Activin Receptor Iib

Ensembl ID : ENSPEMG00000012381
Gene Symbol: ACVR2B
1 Cross references
257 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSPEMG00000031414
Gene Symbol: ADORA1
3 Cross references
269 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSPEMG00000031022
Gene Symbol: ADORA2A
3 Cross references
260 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSPEMG00000030868
Gene Symbol: ADORA2B
3 Cross references
200 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSPEMG00000019889
Gene Symbol: ADORA3
3 Cross references
89 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSPEMG00000021134
Gene Symbol: ADA
1 Cross references
216 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSPEMG00000020024
Gene Symbol: ADRM1
2 Cross references
255 Possible Orthologues:

Adrenergic Receptor, Alpha 1a

Ensembl ID : ENSPEMG00000021686
Gene Symbol: ADRA1A
1 Cross references
201 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).